Vascular access implant and access implant system
Patent Information
- Application Number
- DE502019012464
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-12-21
- Filing Date
- 2019-12-18
- Publication Date
- 2024-11-28
- Estimated Expiration
- 2039-12-18
AI Technical Summary
Current vascular access implants for connecting intracorporeal and extracorporeal blood circuits during treatments like dialysis cause patient discomfort, risk of infection, and adverse cardiovascular effects due to needle punctures and vasodilation, leading to potential blood loss and heart disease.
A vascular access implant with mechanically designed arterial and venous connections that can be securely and painlessly coupled and decoupled, featuring adjustable interfaces, self-disinfecting units, energy harvesting, and wireless communication for autonomous operation and sterility, reducing the need for needle punctures and minimizing cardiovascular strain.
The solution provides a secure, sterile, and pain-free connection for blood treatment, reducing the risk of infection and cardiovascular complications, while allowing for efficient and autonomous operation of the implant, enhancing patient comfort and treatment efficacy.
Description
Technical area
[0001] The present invention relates to a vascular access implant for a connection / coupling / access / connection of an intracorporeal blood circuit with an extracorporeal blood circuit, in particular for (fluid) connection to an extracorporeal blood treatment machine such as a dialysis machine, with an arterial fluid line / blood line which is adapted to be permanently (fluid) connected to an artery of a patient in order to withdraw blood from the artery, with a venous fluid line / blood line which is adapted to be permanently (fluid) connected to a vein of the patient in order to supply blood to the vein, and with a controllable artery-vein connection between the arterial fluid line and the venous fluid line, which, in particular by means of a controllable valve, controls a fluid flow between the arterial fluid line and the venous fluid line.In addition, the invention relates to a vascular access implant system according to the preamble of the independent claim. State of the art
[0002] For example, to connect an intracorporeal blood circuit with an extracorporeal blood circuit, an arteriovenous fistula is created as an abnormal connection between a patient's artery and vein. Such a connection, also called a shunt, allows for increased blood flow through the extracorporeal blood circuit during blood treatment.
[0003] In this procedure, blood is diverted from the artery into the extracorporeal blood circuit or into a first connecting tube of the extracorporeal blood circuit, then subjected to treatment and then, particularly from a dialysis machine, returned to the patient's vein. Adequate blood flow in the extracorporeal circuit is essential for the optimal removal of toxins contained in the blood. Depending on the extracorporeal procedure, very different flow rates are required. They range from approximately 100 ml / min for the treatment of patients in an intensive care unit to 6,000 ml / min for patients on a heart-lung machine. In hemodialysis, for example, a connection of up to 400 ml / min is usually sufficient.
[0004] Patients with chronic kidney failure typically receive a surgically created arteriovenous fistula in the arm. This arteriovenous fistula serves as vascular access during blood treatment. Veins have very thin walls and insufficient blood flow. However, veins can be made to a diameter suitable for frequent punctures. Arteries, on the other hand, have too small a volume and are located very poorly for punctures, but they still provide adequate blood flow. A shunt is an arterialized vein and, due to the increased wall thickness, is a suitable blood vessel for frequent (venous) punctures. This allows the patient to be treated several times a week and punctured with dialysis cannulas.
[0005] Alternatively, a multi-lumen catheter can be placed in the superior or inferior vena cava. If multiple lumens are present, they are contained within a single catheter that encompasses all lumens. Since there is only one vascular access, blood withdrawal and return must occur intermittently, i.e., alternately. This requires special equipment in the dialysis machine. When blood is drawn in, the venous blood line must be automatically compressed, thus preventing the blood from flowing back. A special control mechanism regulates the inflow and return phases.
[0006] WO 2009 / 033177 A1, for example, discloses a system that can be used as a catheter system for dialysis. An implant is implanted under the patient's skin and connected to a blood vessel, such as a vein. The implant has a single closable opening through which a catheter can be inserted and removed. Arterial blood flow is drawn through this opening using suction or negative pressure, delivered to an extracorporeal circuit, treated, and then returned to the intracorporeal bloodstream via a flexible tube, which also extends through the opening into the implant and is surrounded by the drawn-in arterial blood. The flexible tube is long enough to extend deep into the vein.Thus, the arterial blood is drained upstream of a single blood vessel, treated, and then returned downstream of the blood vessel.
[0007] WO 03 / 000314 A2 discloses a fistula between a patient's artery and vein that can be controlled by a controllable valve and opened (open state) or closed (closed state). A control unit regulates the mechanical valve. Intermediate stages between the open and closed states are not provided.
[0008] US 2004 / 0133173 A1 discloses an implantable access device for connecting the intracorporeal blood circuit to an extracorporeal blood circuit, in this case for hemodialysis, comprising a rigid structure that provides both an arterial access and a venous access. Both the arterial access and the venous access have an opening in a housing that can be mechanically closed.
[0009] US Pat. No. 6,582,409 B1 discloses an implantable arteriovenous fistula that connects to an artery and a vein and is suitable for hemodialysis. This implantable arteriovenous fistula has a specially defined needle entry area within a frame that is completely embedded in the body. Using special needles that are inserted through the patient's skin and further into this needle entry area, blood can be withdrawn from the artery and returned to the vein. This creates a connection to an extracorporeal bloodstream.
[0010] EP 1 622 657 B1 discloses a dialysis valve comprising a tube fluidically connected between the vein and the artery, and further comprising a pneumatically actuated bellows. The bellows defines an inner chamber, and the tube is arranged within the chamber such that when the bellows changes in length, a corresponding portion of the tube also changes in diameter. This allows flow between the artery and the vein to be controlled according to the adjustable diameter of the tube, and the tube functions as an adjustable throttle.
[0011] US 8,652,084 B2 discloses a vascular access implant comprising an arteriovenous shunt and corresponding anastomotic valves. Specifically, the implantable vascular access implant comprises a first flexible shunt that transports blood from the arterial anastomotic valve to a fluid control unit, and a second flexible shunt that transports blood from the fluid control unit back to the venous anastomotic valve 14. To connect an external tube, a needle is inserted through the patient's skin into the first flexible shunt.
[0012] US 2014 / 0276345 A1 discloses a vascular access implant with two valves connected to each other via a tube. The two valves can be rotated between a first and second position to thereby control fluid flow.
[0013] However, all of these state-of-the-art systems have the disadvantage that the patient must be punctured with needles to gain access to the bloodstream, which is painful for the patient and weakens the organs and damages blood vessels, or that blood is drawn and released from a single blood vessel, which has a negative effect on the heart. There are also disadvantages regarding the risk of infection. There is also a risk of dilation of the blood vessels due to relaxation of the vascular muscles, a process known as vasodilation. Due to the greater resistance and the associated increased strain on the heart, conventional systems contribute to heart disease as a consequence of vasodilation. There is also always the risk that the needles will become loose and cause inadvertent blood loss to the surrounding area. Summary of the invention
[0014] It is therefore the object of the invention to avoid or at least mitigate the disadvantages of the prior art and, in particular, to provide a vascular access implant that allows a painless and safe connection / attachment of an intracorporeal blood circuit to an extracorporeal blood circuit, increases the safety and sterility of the connection and, at the same time, reduces the risk of infection, is self-sufficient and avoids physically adverse side effects due to dialysis treatment.
[0015] The object is achieved with regard to the vascular access implant by the features of claim 1 and with regard to the vascular access implant system by the features of claim 12.
[0016] According to the invention, the vascular access implant is thus adapted to be connected to the extracorporeal blood circuit, in particular for blood treatment, via a mechanically designed arterial (coupling) connection and a mechanically designed venous (coupling) connection, in a detachable, painless and safe manner, i.e., connectable and unconnectable.
[0017] The two connectors are designed and adapted to protrude from the patient's skin for detachable coupling, thus allowing a simple and secure connection. Thus, the vascular access implant essentially comprises a first conduit / structural section that is implanted in the body, separated from the surrounding area by the skin, and connects the artery and vein to the first conduit / structural section of the access implant. Furthermore, the vascular access implant comprises a second structural section that protrudes through the skin outside the body and forms a mechanically configured (coupling / coupling) connection to which the extracorporeal blood circuit can be connected and disconnected. The first structural section and the second structural section of the vascular access implant are connected to each other (mechanically and fluidically).This provides a defined interface, particularly for blood treatment, which can be connected painlessly, is comfortable to wear for the patient, and ensures a safe and sterile connection.
[0018] According to the invention, the vascular access implant thus comprises an arterial port adapted to protrude from the patient's skin, is firmly fluidically connected to the arterial fluid line, and is adapted to be coupled and decoupled as an arterial access to a first (external) tube of the extracorporeal blood circuit. Furthermore, the vascular access implant comprises a venous port adapted to protrude from the patient's skin, is firmly fluidically connected to the venous fluid line, and is adapted to be connected as a venous access to a second (external) tube of the extracorporeal blood circuit.The vascular access implant is particularly designed to be completely absorbed into the patient's body, with only the arterial connection / connection piece and the venous connection / connection piece being easily, safely and quickly connected from the outside and preferably protruding from the body through the patient's skin.
[0019] In terms of design, the basic idea outlined above is essentially implemented in that the vascular access implant has the arterial connection and the venous connection, each of which is connected to the arterial or venous fluid line via a line. The other end of the line (the end of the line facing away from the arterial or venous fluid line) has a separate or shared adapter or adapter structure for coupling, which is shaped such that the adapter protrudes through the skin and is easily accessible from the outside or outside the body. From the outside, a defined needle puncture structure of the adapter can be inserted into the adapter, for example with a needle, to establish a fluid connection via the needle, or the adapter can be connected and disconnected without a needle, for example using a Luer connector.
[0020] In this context, the terms "coupleable" and "coupleable and decoupleable" mean that one end of a (first) fluid channel is directly connected to another end of a different (second) fluid channel and is fixedly positioned relative to each other and is permanently held in this position until a desired decoupling is given by a user or by a control command, so that a secure and detachable fluid connection is created between the two fluid channels.
[0021] The arterial connection has an arterial connection lock / arterial coupling, which firmly connects the first tube by means of a positive and / or frictional connection, and / or the venous connection has a venous connection lock, which firmly connects the second tube by means of a positive and / or frictional connection. The connection lock ensures that the line or tube is and remains safely, correctly, and firmly connected to the corresponding connection and fluidically connected. The connection lock, in a sense, firmly connects the tube to the corresponding connection. Thanks to the positive and / or frictional connection, the tube can also be easily and quickly detached from the connection by releasing the positive or frictional connection.
[0022] Furthermore, the arterial coupling and / or the venous coupling connect the respective tube via an adjustable undercut / undercut structure, such as a hose coupling / quick coupling or a Luer lock connection, in a form-fitting manner, and / or via a magnetic or magnetizable structure, such as a magnetic coupling or a hysteresis coupling, in a force-fitting manner. The undercut and / or magnetizable structure offers the advantage of a detachable, painless, and secure connection.
[0023] Advantageous embodiments are claimed in the subclaims and are explained below.
[0024] According to a potentially independently claimable aspect of the invention, the vascular access implant can have an autonomous power supply / an autonomous power supply device that provides power to components of the vascular access implant. To operate autonomously, the vascular access implant requires electrical power for its components, in particular for its electromechanical and electrotechnical components, such as sensors. It receives this power from the autonomous power supply.
[0025] According to another preferred, possibly independently claimable embodiment, the autonomous energy supply of the vascular access implant comprises an energy harvester / nanogenerator that converts energy from the patient's body temperature and / or the patient's movement and / or the pulsation of a vessel or the controllable artery-vein connection into electrical energy. The access implant can "harvest" the required electrical energy using the energy harvester, which uses the body temperature, movement, or pulsation as an energy source. The energy harvester converts mechanical energy into electrical energy, particularly by means of the piezoelectric effect, and / or converts temperature differences into electrical energy using the thermoelectric effect, using thermoelectric generators or pyroelectric crystals.
[0026] In particular, the autonomous power supply can comprise an energy storage device, in particular an accumulator such as a lithium-ion battery, to store electrical energy in the autonomous power supply of the vascular access implant. The accumulator can ensure that the access implant provides its components with the required electrical energy over a period of time to operate autonomously and reliably fulfill its function.
[0027] According to a further embodiment, electrical energy can be supplied to the autonomous energy supply via wireless / contactless energy transmission, in particular via inductive energy transmission. Preferably, the energy storage device of the autonomous energy supply can be charged via contactless energy transmission. For this purpose, the autonomous energy supply of the access implant preferably has an antenna of a (coupling) coil for charging via inductive coupling with a magnetic flux in the near field. Thus, the access implant can be held a few centimeters away from a suitable transmitter with a power supply (with a transmitting coil), and the transmitter supplies the access implant with energy contactlessly.
[0028] It may be useful if the charge level of the energy storage device is displayed visually, particularly via a subcutaneous light source such as an LED, or readable via wireless transmission. The access implant preferably has a light source / lamp, particularly an LED or an LCD display, which is placed directly under the patient's skin so that the skin's light permeability is sufficient to display information, such as charge level, coupling status, or therapy progress, through the skin.
[0029] In a preferred, optionally independently claimable embodiment, the arterial port and / or the venous port and / or the controllable artery-vein connection can comprise a disinfection unit / sterilization unit, in particular a self-disinfecting one, as a component of the vascular access implant. This disinfection unit has a biocidal or antibacterial effect and kills bacteria and germs or at least inhibits their growth. The disinfection unit, which is integrated into the vascular access implant, serves to ensure the sterility of the arterial port and / or the venous port and / or the controllable artery-vein connection, so that the access implant can autonomously fulfill its sterility requirements. The risk of infection is reduced.
[0030] Preferably, the disinfection unit / sterilization unit is adapted to (actively) emit UV light or plasma onto the arterial connection and / or the venous connection and / or the artery-vein connection and / or the disinfection unit can have a (passive) antibacterial coating and / or the disinfection unit can have a self-disinfecting material that can be activated by light. If the disinfection unit is designed as a UV lamp that emits UV light, it can, for example, kill bacteria and germs using short-wave radiation before being connected to the extracorporeal bloodstream, and thus actively disinfects the arterial or venous connections as well as the artery-vein connection. If the arterial and / or venous connection is coated or coated with an antibacterial coating,that act as a disinfection unit, passive disinfection is provided for a longer period of time, especially permanently. Alternatively or additionally, the disinfection unit can have a refillable container within the access implant, in which a disinfectant / sterilant is stored that can be supplied to the arterial and / or venous connection.
[0031] In a further, possibly independently claimable embodiment, the vascular access implant can comprise an identification element and / or a transponder / transmitter, in particular an RFID chip, as a component for contactless identification of the access implant using a suitable reader. This unique identification ensures that the intracorporeal blood circuit is also connected to the correct extracorporeal blood circuit. Patient data can also be sent contactlessly to the blood treatment machine in order to (automatically) adjust the blood treatment therapy accordingly.
[0032] The vascular access implant can further preferably comprise a communication unit, which can be used independently if necessary, as a component and is adapted to receive and transmit data without contact. The communication unit can establish a data connection, for example, between the extracorporeal blood treatment machine or a physician's computer for inputting updated data and the access implant. For example, after treatment with a dialysis machine, current data can be stored in the access implant, and a history can be saved in the access implant itself. During the next treatment, these values are then made available to the blood treatment machine, which evaluates the values and adjusts or sets the treatment accordingly.
[0033] According to a possibly independently claimable aspect of the invention, the vascular access implant can have a connection dislocation detection / connection dislocation detection device as a component of the access implant at the arterial connection and / or at the venous connection, which is adapted, in particular by means of a Hall sensor and / or a reed sensor / reed relay, to detect whether the arterial connection or the venous connection is correctly coupled or whether the first or second tube is correctly connected to the arterial connection or the venous connection. The connection dislocation detection serves as a safety and monitoring device of the access implant, which can detect an unintentional detachment of the tube or blood flow without a correct connection and, for example, send a corresponding control or alarm signal. This makes the connection even more secure.
[0034] In particular, according to a further, possibly independently claimable aspect of the invention, the controllable artery-vein connection can continuously, in particular by means of a proportional valve, or discretely adjust a flow cross-section and / or a flow and / or a fluid resistance / flow resistance of the fluid connection between the arterial fluid line and the venous fluid line. Preferably, the controllable artery-vein connection additionally comprises a check valve that prevents unwanted backflow from the venous fluid line to the arterial fluid line. The controllable artery-vein connection or the controllable proportional valve allows precise adjustment of the pressure and flow, in particular to optimally support blood treatment.The artery-vein connection of the access implant can be discretely controlled to achieve two states, for example, an open state in which the artery-vein connection is completely open and the fluid connection is established, and a closed state in which the artery-vein connection is completely closed. Or it can assume several discrete states to assume intermediate states between the open state and the closed state. Alternatively, the artery-vein connection can be continuously adjustable, for example using a proportional valve, in order to be able to react to hemodynamic changes. Blood flow in the artery-vein connection can be individually adjusted and, in particular, by throttling it, can prevent coagulation while simultaneously relieving cardiac stress.In particular, the controllable artery-vein connection is closed when the patient is not connected to the extracorporeal blood circuit. The controllable artery-vein connection prevents side effects of blood treatment, such as cardiac hypertrophy or steal syndrome.
[0035] Preferably, and optionally independently claimable, the vascular access implant can have a flow sensor and / or a pressure sensor that measures a flow or a pressure in the controllable artery-vein connection and / or at the arterial connection and / or at the venous connection. The flow or the pressure serves in particular to control the artery-vein connection and forms the basis for this. The flow sensor measures both a quantity and a sign (possible recirculation) of the blood flow and is important as a parameter for treatment. The pressure sensor measures a pressure, in particular of the artery-vein connection, and serves, in particular together with the measured flow, as a further parameter for the control.
[0036] According to another preferred and possibly independently claimable embodiment, the vascular access implant can have a central control unit by means of which the components of the vascular access implant are controlled. The central control unit receives data from components such as sensors, processes it, and sends it to components such as the communication unit. The access implant can be controlled automatically by means of the central control unit.
[0037] It is advantageous if a controllable valve, in particular an electromechanical valve, is provided between the arterial fluid line and the arterial connection and / or a check valve is provided between the venous fluid line and the venous connection. If the connection to the extracorporeal blood circuit at the arterial connection is interrupted, the controllable valve can be quickly closed, preventing unwanted blood loss into the environment. On the other hand, the check valve at the venous connection provides a safety element that prevents blood flow out of the venous connection. Since blood should only be supplied to the venous connection during blood treatment and not drained away, a check valve is sufficient to close the venous connection. In particular, the actively controlled valve of the arterial connection is controlled by the central control unit.
[0038] It is advantageous if both the arterial connection and the venous connection are formed in a single, preferably one-piece adapter, particularly in the form of a double connector, which can only be coupled together with a corresponding mating adapter. This ensures that one connection, for example, the arterial connection, is not connected to a tube while the other connection, for example, the venous connection, is not separated from a tube. The single adapter allows for connection to both the arterial and venous connections only simultaneously.
[0039] According to a preferred and possibly independently claimable embodiment, the vascular access implant can have a housing that completely encloses / encloses / encompasses all components of the access implant, in particular the electrical components, except for the arterial and venous fluid lines and the arterial and venous connections, in order to create a sterile barrier between the components and the body, wherein the housing has a biocompatible material on its exterior. By means of the housing, various components, including non-biocompatible ones, can be integrated into the access implant, which is of immense importance, especially for electrical components. Alternatively, the vascular access implant can have a (relatively) rigid biocompatible connecting structure that rigidly connects the biocompatible components of the vascular access implant.
[0040] In particular, the arterial and / or venous connection has a sealing ring. This ensures a lossless blood connection.
[0041] According to a potentially independently claimable aspect of the invention, the distance between the arterial fluid line and the venous fluid line in the access implant can be adjustable. This ensures that the access implant can be used for different anatomies, since the distance between an artery and a vein usually varies from patient to patient. The adjustable distance can be realized, for example, by an artery-vein connection with adjustable length.
[0042] The invention also relates to a vascular access implant system with a vascular access implant and an extracorporeal blood circuit. A vascular access implant according to the invention is inserted into the vascular access implant system, wherein an arterial counter-adapter is provided at one end of a first tube of the extracorporeal blood circuit, which can be positively and / or non-positively coupled to an arterial adapter of the arterial connection, and / or a venous counter-adapter is provided at one end of a second tube of the extracorporeal blood circuit, which can be positively and / or non-positively coupled to a venous adapter of the venous connection. Similar to a plug-and-socket connection / plug connection, the adapter and counter-adapter form a coordinated system of the access implant system.The adapter fits onto the corresponding mating adapter to establish a fluid connection between the adapter and the mating adapter. The adapter and mating adapter can be designed differently. For example, they can be designed as complementary quick-coupling components or as a Luer-Lock connection. The system of adapter and mating adapter of the access implant system forms a defined interface and ensures a secure connection of the intracorporeal blood circulation to the extracorporeal blood circulation. Short description of the characters
[0043] The invention is explained in more detail below using a preferred embodiment with the aid of the accompanying figures. They show: Fig. 1 is a schematic plan view of a vascular access implant according to the invention of an access implant system according to the invention according to a preferred embodiment, Fig. 2 is a schematic plan view of the vascular access implant inserted into an arm of a patient from Fig. 1 , and Fig. 3 a schematic diagram view of the vascular access implant and access implant system of Fig. 1 . Detailed description of preferred embodiments
[0044] Figures 1 to 3 show a vascular access implant 1 according to the invention and an access implant system 2 according to the invention according to a preferred embodiment with a plurality of components.
[0045] The access implant 1 serves as an interface between an intracorporeal blood circuit 4 of a patient 6 and an extracorporeal blood circuit 8 to withdraw blood from the patient 6, treat it using a blood treatment machine 10 in the form of a dialysis machine, and then return it to the patient 6. Various blood treatments can be performed using the extracorporeal blood circuit 8, such as hemodialysis, hemodiafiltration, ultrafiltration, or (therapeutic) apheresis to purify the blood of toxins.
[0046] The access implant 1 has an arterial fluid line 12 (see Fig. 3), for example, in the form of a flexible arterial silicone line or a line made of a suitable vascular substitute material, which extends into an artery 14 of the patient 6 and is fluidically connected thereto. Alternatively, the arterial fluid line 12 can also be firmly sutured to the artery 14. A quantity of blood can be withdrawn or removed / removed from the artery 14 of the patient 6 via the arterial fluid line 12.
[0047] The arterial fluid line 12 directs the extracted blood to a rigid arterial connection 16. This arterial connection 16 extends through the skin 17 of the patient 6, thus breaking through the skin barrier, so to speak, so that the arterial connection 16 is easily accessible from the outside (outside the body) and can be connected to and disconnected from the extracorporeal blood circuit 8. For this purpose, the arterial connection 16 has an arterial adapter 18 or is designed as an arterial adapter 18, which is adapted to be positively and / or magnetically (i.e., force-fitting) coupled to and disconnected from an arterial mating adapter 20 of the extracorporeal blood circuit 8 (see Fig. 3 The arterial adapter 18 is fluid-tightly connected to the arterial fluid line 12 and forms, so to speak, the terminal (blood) outlet of the access implant 1 to the extracorporeal blood circuit 8.
[0048] The arterial adapter 18 of the intracorporeal blood circuit 4 and the arterial counter-adapter 20 of the extracorporeal blood circuit 8 together form a coordinated system of the access implant system 2 and a defined interface. The arterial adapter 18 fits onto the corresponding arterial counter-adapter 20 to establish a lossless, simple, and detachable fluid connection between the adapter 18 and the counter-adapter 20. The counter-adapter 20 forms a terminal section of a first (arterial) tube 22 of the extracorporeal blood circuit 8. The adapter 18, as one end of the (first) fluid channel (of the intracorporeal blood circuit 4), is thus directly connected to the counter-adapter 20, as the other end of the (second) fluid channel (of the extracorporeal blood circuit 8), and is fixedly positioned relative to one another and held in this position permanently until a user intentionally disconnects them.This creates a secure and detachable fluid connection between the two blood circuits 4, 8. The arterial adapter 18 functions as an arterial connection lock 19. A maximum magnetic force of attraction is generally sufficient to create a force-locking arterial connection lock 19. In particular, the arterial connection lock 19 is designed such that a strong pull on the mating adapter 20 and thus on the adapter 18, regardless of the direction, releases the connection, thus minimizing the risk of the access implant 1 being torn out, resulting in significant damage.
[0049] Analogous to the arterial side of the access implant 1, the vascular access implant 1 also has a rigid venous connection 24 on its venous side with analogous features of a venous adapter 26, which can be connected in a force-fitting and / or form-fitting manner to a corresponding venous mating adapter 28 of a second tube 30 of the extracorporeal blood circuit 8. The venous adapter 26 thus forms a venous connection lock 27. Via the connection to the venous connection 24, the purified or treated blood can be fed back to the access implant 1. The blood flows to a venous fluid line 32 connected to the venous connection 10 in the form of a flexible venous silicone line, which extends into a vein 34 of the patient 6 and is fluidically connected to it. Thus, a fluid connection is established between the second tube 30 and the vein 34 of the patient 6.Through the arterial connection 16 and the venous connection 24, a fluid circuit is created which connects the intracorporeal blood circuit 4 of the patient 6 with the extracorporeal blood circuit 4.
[0050] The operation of the vascular access implant 1 according to the preferred embodiment is explained below.Thus, instead of, as is the case with a commonly used shunt, for example, each time the patient 6 is treated, a cannula is inserted through the skin 17 of the patient 6 into the vessel (artery / vein) of the patient 6, thus creating a blood collection point in order to drain the blood for extracorporeal blood treatment, and also performing a second puncture in order to return the purified blood to the vein of the patient 6, the access implant 1 provides a fully implantable interface device which is permanently connected to both the artery 14 and the vein 34 of the patient and which provides a defined common connection with two separate fluid connections or two separate connections (with arterial connection 16 and venous connection 24) to the extracorporeal blood circuit 8.The extracorporeal blood circuit 8 can be coupled to the access implant 1 (detachably) and painlessly, without restrictions such as the number of connections and disconnections or a change of location, as is the case with cannula insertions (vascular damage), having to be observed.
[0051] The access implant 1 further comprises a housing 36, the exterior of which is constructed of biocompatible materials and, due to its structural design, is completely and permanently implantable in the body of the patient 6. Only the arterial port 16 or the arterial adapter 18 and the venous port 24 or the venous adapter 26 protrude from the patient's skin 15. The housing 36 encloses the access implant 1, except for the protruding arterial fluid line 12, the protruding arterial port 16, the protruding venous fluid line 32, and the protruding venous port 24.
[0052] In addition, the vascular access implant 1 has a branch 38 extending from the arterial fluid line 12, which is connected to the venous fluid line 32 via a controllable artery-vein connection 40 to short-circuit the artery 14 with the vein 34, similar to a bypass. A controllable electromechanical proportional valve 42 is interposed in the artery-vein connection 40 to continuously control the flow in the artery-vein connection 40. The proportional valve 42 can be continuously closed from an open position and then opened again, thereby also realizing states between an open position and a closed position. The proportional valve 42 can be used to change the resistance or flow in the artery-vein connection 40 within milliseconds in order to respond to hemodynamic changes.Blood flow in the artery-vein connection 40 can thus be individually adjusted, and coagulation can be prevented by throttling it, while simultaneously relieving cardiac pressure. If the patient 6 is connected to the blood treatment machine 10 via the extracorporeal blood circuit 8, the controllable artery-vein connection 40 is opened. When the patient 6 is no longer connected to the extracorporeal blood circuit 8, it is closed.
[0053] In order to prevent recirculation of blood into the artery 14 in the artery-vein connection 40, a check valve 44 is also provided in the artery-vein connection 40, which only allows the flow direction from the artery 14 to the vein 34.
[0054] A controllable electromechanical valve 46 is provided in the arterial fluid line 12 upstream of the arterial connection 8 or upstream. This valve switches between an open and a closed state. Alternatively, the controllable valve 46 can also continuously change the flow. The controllable valve 46 is designed to ensure that when the arterial counter-adapter 20 is disconnected from the arterial connection 16, the blood flow is immediately interrupted to prevent it from being released uncontrollably into the environment.
[0055] A check valve 48 is also provided in the venous fluid line 32 upstream of the venous connection 24. This does not necessarily have to be actively operable, as it closes the venous connection 24 from the environment in a pressure-dependent manner when disconnected. The venous connection 24 only allows blood to flow into the access implant 1 via the check valve 48. Thus, the check valve 48 securely closes the venous connection 24 and ensures that no unwanted exit point of the patient's 6 blood system occurs.
[0056] In order to be able to act or be actuated autonomously and independently, the access implant 1 has an autonomous energy supply 50 which provides electrical energy for the (electrotechnical) components of the access implant 1. On the one hand, the autonomous energy supply 50 has an energy storage device 52 in the form of a rechargeable lithium-ion battery in order to store electrical energy over a longer period of time. On the other hand, the autonomous energy supply 50 has a first energy harvester 54 in the form of a thermoelectric generator which converts temperature differences into electrical energy by means of the thermoelectric effect and feeds it to the energy storage device 52. And a second energy harvester 56 which can convert the kinetic energy of the patient 6 into electrical energy and feeds it to the energy storage device 52.With the two energy harvesters 54, 56, the autonomous energy supply 50 of the access implant 1 can be continuously supplied with electrical energy without the need to be connected to an external charging station. In order to be able to charge the energy storage device 52 of the autonomous energy supply 50 independently of the energy harvesters 54, 56, if necessary, the autonomous energy supply 50 has an antenna of a coupling coil or charging coil 58, so that it can also be charged wirelessly if necessary by means of inductive energy transmission in the near field. This allows the access implant 1 to be held a few centimeters away from a complementary external coupling coil in order to inductively charge the energy storage device 52 via the charging coil 58 without contact.
[0057] The access implant 1 also has an indicator 60 in the form of an LED to indicate the charge level of the energy storage device 52. The LED has sufficient luminosity to be visually perceived through the skin 17 of the patient 6. For example, the charge level of the energy storage device 52 can be indicated by a red flashing LED when the energy level is low.
[0058] To sterilize the arterial port 16 and the venous port 24 for coupling / connection, the access implant 1 includes an antibacterial disinfection unit 62 in the form of a UV lamp (emitter) as a component of the access implant 1. The disinfection unit 62 can disinfect or sterilize the surfaces of the two ports 16, 24 by emitting UV light. In addition, the arterial and venous ports 16, 24 comprise a material with an antibacterial effect or an antibacterial coating to achieve long-lasting passive disinfection of the ports 16, 24. The artery-venous connection 40 can also be irradiated and disinfected using UV light from the disinfection unit 62.
[0059] Data can be transmitted to the extracorporeal blood treatment machine 10 via a communication unit 64 as a further component, in particular via a Bluetooth® or WLAN connection, in order to optimally adjust a therapy. Data can also be transmitted to the access implant via the communication unit 64. The communication unit 64 is thus designed to communicate wirelessly with other machines or systems.
[0060] Also connected to the communication unit 64 is an identification element 66 (as a further component) in the form of an RFID chip or an NFC coil, arranged within the housing 36 of the vascular access implant 1. Using the identification element 66, the patient 6 can be uniquely identified by other machines. For example, an external reader of the blood treatment machine 10 can wirelessly read the data from the identification element 66 in addition to the data transmitted via the communication unit 64 and adapt and adjust a therapy accordingly for the patient 3. Since, for example, an NFC coil has only a very short range, data security can be increased because only data is transmitted in the near field. Reading the patient data by an unauthorized person is made more difficult because the data would have to be accessed in the immediate vicinity.In particular, the data in the access implant 1 can also be encrypted, with the communication unit 64 or the central control unit 70 preferably performing the encryption. The blood treatment machine 10, which knows the encryption key, can then decrypt this encrypted data accordingly. Similarly, the access implant 1 can also decrypt encrypted data from the blood treatment machine 10.
[0061] To ensure correct connection to the arterial and venous ports 16, 24, the access implant 1 includes a port dislocation detection device 68 (as an additional component) that uses a reed sensor and / or Hall sensor to detect whether the respective mating adapter 20, 28 is correctly connected to the adapter 18, 26. The port dislocation detection device 68 measures a magnetic or changing magnetic flux and thereby determines whether the respective port 16, 24 is correctly connected. A correct connection is extremely important because it acts as a safety device, detecting any intentional or unintentional detachment of the tube 22, 30 and subsequently interrupting the fluid connection via the controllable valve 46 to prevent blood loss. In particular, the check valve 48 can also be (electromechanically) closable.If, for example, only the arterial tube 22 accidentally detaches, the check valve 48 can be closed, triggering a pressure alarm on the blood treatment machine 10 and stopping a blood pump. Alternatively, the access implant 1 can also close both valves 46, 48 and send a control command or alarm command to the blood treatment machine 10 via the communication unit 64, which then stops the blood treatment and displays an alarm signal or error information associated with the error on the display.
[0062] The vascular access implant 1 further comprises a central control unit 70, which processes received data / signals and can control all (electrotechnical) components of the access implant 1. The control unit 70 is thus the central hub of the access implant 1 for all electrical components. The central control unit 70 controls the proportional valve 42 and receives data from it regarding a current (valve) state, controls the controllable valve 46 and also receives data from it regarding its state, controls the autonomous energy supply 50 with the energy storage unit 52, the two energy harvesters 54, 56 and the charging coil 58 and receives data from it regarding, for example, a current charge state, a current maximum charge capacity, energy generation and energy consumption by the components, controls the indicator 60 and optionally an acoustic signal generator, controls the disinfection unit 62 and, if necessary, receivesError messages, for example if the UV lamp is defective, are controlled by the communication unit 64 and received data from it, and if necessary, it controls the identification element 66 and receives data from the connection dislocation detection 68. In addition, the control unit 70 stores relevant data, such as patient data, therapy data, component data, and reference data, in its memory.
[0063] The artery-venous connection 40 has a pressure sensor 72 and a flow sensor 74, which measures the pressure and flow in the artery-venous connection 40 and provides this data to the central control unit 70. The data or parameters of the pressure sensor 72 and the flow sensor 74 form the basis for controlling the proportional valve 42 of the controllable artery-venous connection 40, which can be used to prevent side effects of blood treatment, such as cardiac hypertrophy.
[0064] With the access implant 1 according to the invention or the access implant system according to the invention, the patient is provided with a device or a system for pain-free coupling with increased safety, reduced risk of infection, improved patency and better therapy conditions with less vasodilation, lower risk of heart disease and lower susceptibility to involuntary blood loss. List of reference symbols
[0065] 1Vascular access implant 2Vascular access implant system 4Intracorporeal blood circuit 6Patient 8Extracorporeal blood circuit 10Blood treatment machine 12Arterial fluid line 14Patient artery 16Arterial connector 17Patient skin 18Arterial adapter 19Arterial connection lock 20Arterial counter adapter 22First tube 24Venous connector 26Venous adapter 27Venous connection lock 28Venous counter adapter 30Second tube 32Venous fluid line 34Patient vein 36Housing 38Branch 40Artery-vein connection 42Proportional valve 44Check valve 46Controllable valve 48Check valve 50Autonomous energy supply 52Energy storage 54First Energy Harvester 56Second Energy Harvester 58Charging Coil 60Indicator 62Disinfection Unit 64Communication Unit 66Identification Element 68Connector Dislocation Detection 70Central Control Unit 72Pressure Sensor 74Flow Sensor
Claims
1. A vascular access implant (1) for connecting an intracorporeal blood circulation (4) to an extracorporeal blood circulation (8), in particular for a fluidic connection to an extracorporeal blood treatment machine (10), comprising an arterial fluid line (12) adapted to be permanently connected to an artery (14) of a patient (6), comprising a venous fluid line (32) adapted to be permanently connected to a vein (34) of the patient (6), comprising a controllable artery-vein-connection (40) between the arterial fluid line (12) and the venous fluid line (32), which controls, in particular by means of a controllable valve (42), a fluid flow between the arterial fluid line (12) and the venous fluid line (32), characterized by an arterial port (16) which is adapted to protrude from a patient's skin and which is in fixed fluid connection with the arterial fluid line (12) and is adapted, as an arterial access, to be able to be coupled to and decoupled from a first hose (22) of the extracorporeal blood circulation (8), and a venous port (24) which is adapted to protrude from a patient's skin, and which is in fixed fluid connection with the venous fluid line (32) and is adapted, as a venous access, to be able to be coupled to and decoupled from a second hose (30) of the extracorporeal blood circulation (8), wherein the arterial port (16) comprises an arterial connecting lock (19) which firmly connects to the first hose (22) via an undercut structure in a form-fitting manner or via a magnetic or magnetizable structure in a force-fitting manner, and / or the venous port (24) comprises a venous connecting lock (27) which firmly connects to the second hose (30) via an undercut structure in a form-fitting manner or via a magnetic or magnetizable structure in a force-fitting manner.
2. The vascular access implant (1) according to claim 1, characterized in that the vascular access implant (1) comprises an autonomous energy supply (50) which provides energy for components (42; 46; 62; 64; 66; 68; 70; 72; 74) of the vascular access implant (1).
3. The vascular access implant (1) according to claim 2, characterized in that the autonomous energy supply (50) comprises an energy harvester (54; 56) which converts energy of a body temperature of the patient (6) and / or of a movement of the patient (6) and / or of a pulsation of a vessel or the controllable artery-vein-connection (40) into electrical energy and supplies it to the autonomous energy supply (50).
4. The vascular access implant (1) according to claim 2 or 3, characterized in that the autonomous energy supply (50) comprises an energy storage device (52), in particular a lithium ion accumulator, for storing electrical energy in the autonomous energy supply (50) of the vascular access implant (1).
5. The vascular access implant (1) according to one of the claims 2 to 4, characterized in that electrical energy can be supplied to the autonomous energy supply (50) by means of wireless / contact-less energy transmission, in particular via inductive energy transmission.
6. The vascular access implant (1) according to claim 5, characterized in that the autonomous energy supply (50) comprises an antenna of a coupling coil (58) for wireless energy transmission, by means of which energy can be supplied to the autonomous energy supply (50) in contact-less manner via inductive coupling with a magnetic flow in the near field.
7. The vascular access implant (1) according to one of the claims 1 to 6, characterized in that the arterial port (16) and / or the venous port (24) and / or the controllable artery-vein-connection (40) comprise a disinfection unit (62) as a component of the vascular access implant (1), which has an anti-bacterial effect.
8. The vascular access implant (1) according to claim 7, characterized in that the disinfection unit (62) emits UV light or a plasma to the arterial port (16) and / or the venous port (24) and / or the controllable artery-vein-connection (40) and / or that the disinfection unit (62) comprises an anti-bacterial coating or an anti-bacterial material and / or comprises a self-disinfecting material which can be activated by means of light.
9. The vascular access implant (1) according to one of the claims 1 to 8, characterized in that the vascular access implant (1) comprises an identification element (66), in particular an RFID chip, as a component of the vascular access implant (1), for contact-less identification by means of a reader and / or a communication unit (64) as a component of the vascular access implant (1), which is adapted to receive and send data in a contact-less manner.
10. The vascular access implant (1) according to one of claims 1 to 9, characterized in that the vascular access implant (1) comprises a port dislocation detection (68) as a component of the vascular access implant (1) at the arterial port (16) and / or at the venous port (24), which is adapted to detect, in particular by means of a Hall sensor and / or Reed sensor, if the arterial port (16) and the venous port (24) are correctly coupled.
11. The vascular access implant (1) according to one of claims 2 to 10, characterized in that the autonomous energy supply (50) supplies a sufficient amount of energy to the disinfection unit (62) and / or the identification element (66) and / or the communication unit (64) and / or the port dislocation detection (68) as components of the vascular access system (1).
12. A vascular access implant system (2) comprising a vascular access implant and an extracorporeal blood circulation (8), characterized in that a vascular access implant (1) according to one of the claims 1 to 11 is employed, and an arterial mating adapter (20) is provided at one hose end of a first hose (22) of the extracorporeal blood circulation (8), wherein the arterial mating adapter is able to be coupled to the arterial port (16) as adapter (18) in a form-fitting and / or force-fitting manner, and / or a venous mating adapter (28) is provided at one hose end of the second hose (30) of the extracorporeal blood circulation (8), wherein the venous mating adapter is able to be coupled to the venous port (24) as adapter (26) in a form- and / or force-fitting manner.
